Related references
Note: Only part of the references are listed.COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management
Antonis S. Manolis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)
Rheumatic disease and COVID-19: epidemiology and outcomes
Kimme L. Hyrich et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry
Milena A. Gianfrancesco et al.
ARTHRITIS & RHEUMATOLOGY (2021)
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
Victoria Furer et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
COVID-19 and Racial/Ethnic Disparities
Monica Webb Hooper et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19)
Morayma Reyes Gil et al.
JAMA NETWORK OPEN (2020)
Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank
Zahra Raisi-Estabragh et al.
JOURNAL OF PUBLIC HEALTH (2020)
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
Maria Orietta Borghi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season
Lisa A. Grohskopf et al.
MMWR RECOMMENDATIONS AND REPORTS (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Christopher R. Holroyd et al.
RHEUMATOLOGY (2019)
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis
Mohammad Adawi et al.
AUTOIMMUNITY REVIEWS (2019)
Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD
Victoria Furer et al.
RMD OPEN (2019)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
Caroline Gordon et al.
RHEUMATOLOGY (2018)
Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort)
Gamal Chehab et al.
RHEUMATOLOGY (2018)
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
Kathleen L. Dooling et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus
W. Chatham et al.
LUPUS (2017)
The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
Kevin L. Winthrop et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?
Maria Vadala et al.
EPMA JOURNAL (2017)
The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness
Borja Gracia-Tello et al.
LUPUS SCIENCE & MEDICINE (2017)
Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
Jin Kyun Park et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Environmental exposures and the development of systemic lupus erythematosus
Medha Barbhaiya et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study
O. Gronlund et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis
Yafang Huang et al.
MEDICINE (2016)
Vaccination recommendations for adult patients with rheumatic diseases
Mine Durusu Tanriover et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2016)
Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients
Patricia Andrade et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients
Johanna Nagel et al.
ARTHRITIS RESEARCH & THERAPY (2015)
A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
David A. Geier et al.
CLINICAL RHEUMATOLOGY (2015)
Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients
J. Westra et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections
R. K. M. A. C. Luijten et al.
LUPUS (2014)
Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Charlotte Hua et al.
ARTHRITIS CARE & RESEARCH (2014)
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
Zsuzsanna H. McMahan et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study
Helena H. Askling et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2014)
The Risk of Systemic Lupus Erythematosus Associated With Vaccines An International Case-Control Study
Lamiae Grimaldi-Bensouda et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study
Chi Chiu Mok et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
Vibha Jawa et al.
CLINICAL IMMUNOLOGY (2013)
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
Robert A. Eisenberg et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Herpes Zoster Vaccination in SLE: A Pilot Study of Immunogenicity
Joel M. Guthridge et al.
JOURNAL OF RHEUMATOLOGY (2013)
Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes
L. A. Gonzalez et al.
LUPUS (2013)
Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years
Arzu Soybilgic et al.
PEDIATRIC RHEUMATOLOGY (2013)
Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjogren's syndrome
Sandra Gofinet Pasoto et al.
VACCINE (2013)
High Disease Activity: An Independent Factor for Reduced Immunogenicity of the Pandemic Influenza A Vaccine in Patients With Juvenile Systemic Lupus Erythematosus
Lucia M. A. Campos et al.
ARTHRITIS CARE & RESEARCH (2013)
Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
Lisen Arnheim-Dahlstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine
Claire-Anne Siegrist et al.
ANTIVIRAL THERAPY (2012)
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study
Gionata Fiorino et al.
INFLAMMATORY BOWEL DISEASES (2012)
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
C. Chao et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial
W. Winn Chatham et al.
JOURNAL OF RHEUMATOLOGY (2012)
Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus
E. S. Vista et al.
LUPUS (2012)
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
Eduardo F. Borba et al.
RHEUMATOLOGY (2012)
Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study
L. S. Azevedo et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Influenza Vaccination Responses in Human Systemic Lupus Erythematosus Impact of Clinical and Demographic Features
Sherry R. Crowe et al.
ARTHRITIS AND RHEUMATISM (2011)
The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
U. Arad et al.
VACCINE (2011)
Humoral Responses After Influenza Vaccination Are Severely Reduced in Patients With Rheumatoid Arthritis Treated With Rituximab
Sander van Assen et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety
Ewa Wiesik-Szewczyk et al.
CLINICAL RHEUMATOLOGY (2010)
Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus
You-Hyun Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses
Geertrude H. Struijk et al.
KIDNEY INTERNATIONAL (2010)
Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
N. Agmon-Levin et al.
LUPUS (2009)
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus
D. Albert et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Autoimmune response following annual influenza vaccination in 92 apparently healthy adults
N. Toplak et al.
AUTOIMMUNITY REVIEWS (2008)
Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus
K. A. M. Kuruma et al.
LUPUS (2007)
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
A Holvast et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus
P. Tarjan et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
JM Porobic et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Pneumococcal vaccination of patients with systemic lupus erythematosus: Effects on generation of autoantibodies
O Elkayam et al.
AUTOIMMUNITY (2005)
Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus
O Elkayam et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
